Question 1

Does Sculptor Capital Management own INO stock?

Accepted Answer

No. Sculptor Capital Management exited its INO (Inovio Pharmaceuticals) position in Q1 2022. Its Q4 2021 13F listed 713,700 shares worth $3.6M.

Question 2

How many shares of INO does Sculptor Capital Management own?

Accepted Answer

None since Q1 2022, when Sculptor Capital Management exited the position. Its Q4 2021 13F listed 713,700 shares worth $3.6M.

Question 3

What is Sculptor Capital Management's INO position worth?

Accepted Answer

Sculptor Capital Management's INO position was worth $3.6M in its Q4 2021 13F, before the exit in Q1 2022.

Question 4

Is Sculptor Capital Management buying or selling INO?

Accepted Answer

In Q1 2022, Sculptor Capital Management exited its entire INO position.

Question 5

When did Sculptor Capital Management first buy INO?

Accepted Answer

Sculptor Capital Management first reported INO in its Q1 2020 13F and listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$43.08	0
2021-Q4	Unchanged	713,700	0.0%	$3.6M	0.0%	$59.88	0
2021-Q3	Unchanged	713,700	0.0%	$5.1M	0.0%	$85.92	0
2021-Q2	Increased	713,700	+132.6%	$6.6M	0.0%	$111.24	44
2021-Q1	Increased	306,900	+99.3%	$2.8M	0.0%	$111.36	42
2020-Q4	Decreased	154,000	-35.8%	$1.4M	0.0%	$106.20	0
2020-Q3	Decreased	239,700	-22.3%	$2.8M	0.0%	$139.20	0
2020-Q2	Increased	308,300	+22.8%	$8.3M	0.1%	$323.40	33
2020-Q1	New	251,000	-	$1.9M	0.0%	$89.28	36

INO9 quarters

INO
9 quarters